NDC 64406-966

ALPROLIX

Coagulation Factor Ix (recombinant), Fc Fusion Protein

ALPROLIX is a Intravenous Kit in the Plasma Derivative category. It is labeled and distributed by Biogen Inc.. The primary component is .

Product ID64406-966_ec45b956-68f2-468e-9bdb-5c45d08aebf9
NDC64406-966
Product TypePlasma Derivative
Proprietary NameALPROLIX
Generic NameCoagulation Factor Ix (recombinant), Fc Fusion Protein
Dosage FormKit
Route of AdministrationINTRAVENOUS
Marketing Start Date2016-02-18
Marketing CategoryBLA / BLA
Application NumberBLA125444
Labeler NameBiogen Inc.
Active Ingredient Strength0
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 64406-966-01

1 KIT in 1 CARTON (64406-966-01) * 5 mL in 1 VIAL (64406-952-01) * 5 mL in 1 VIAL (64406-045-01)
Marketing Start Date2016-02-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64406-966-01 [64406096601]

ALPROLIX KIT
Marketing CategoryBLA
Application NumberBLA125444
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2016-02-18
Inactivation Date2020-01-31

Drug Details

NDC Crossover Matching brand name "ALPROLIX" or generic name "Coagulation Factor Ix (recombinant), Fc Fusion Protein"

NDCBrand NameGeneric Name
64406-911ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
64406-922ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
64406-933ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
64406-944ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
64406-966ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
64406-977ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
71104-911ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
71104-922ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
71104-933ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
71104-944ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
71104-966ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein
71104-977ALPROLIXCoagulation Factor IX (Recombinant), Fc Fusion Protein

Trademark Results [ALPROLIX]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ALPROLIX
ALPROLIX
86310233 4671660 Live/Registered
BIOVERATIV THERAPEUTICS INC.
2014-06-16
ALPROLIX
ALPROLIX
85411805 4593229 Live/Registered
BIOVERATIV THERAPEUTICS INC.
2011-08-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.